Frédéric Ooms

899 citations

25 papers · 705 indexed · h-index 10

Impact in

Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Synthesis of Organic Compounds
Computational Theory and Mathematics top 2%
- Computational Drug Discovery Methods

Papers in ⓘ

Organic Chemistry 11
- Synthesis and biological activity 3
- Cyclopropane Reaction Mechanisms 3
- Synthesis and Biological Evaluation 2
Molecular Biology 9
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Metabolomics and Mass Spectrometry Studies 2

Co-authors: Bernard Testa (4 shared papers)Johan Wouters (14 shared papers)Pierre‐Alain Carrupt (3 shared papers)Cosimo Altomare (1 shared paper)Marco Catto (1 shared paper)Angelo Carotti (1 shared paper)Francesco Leonetti (1 shared paper)Kai Chen (1 shared paper)
Journals: Acta Crystallographica Section C Crystal Structure Communications (4 papers)Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Entrepreneurship Theory and Practice (2 papers)European Journal of Medicinal Chemistry (1 paper)
Partner nations: Belgium United States Switzerland

In The Last Decade

Frédéric Ooms

24 papers receiving 677 citations

Peers

Countries citing papers authored by Frédéric Ooms

Since Specialization

Citations

This map shows the geographic impact of Frédéric Ooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Ooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Ooms more than expected).

Fields of papers citing papers by Frédéric Ooms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Ooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Ooms. The network helps show where Frédéric Ooms may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Ooms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Ooms Line = papers co-authored together Frédéric Ooms links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase Journal of Medicinal Chemistry ·Corinne Brühlmann, Frédéric Ooms, Pierre‐Alain Carrupt, Bernard Testa, Marco Catto, Francesco Leonetti, Cosimo Altomare, Angelo Carotti	2001	256
2	Molecular Modeling and Computer Aided Drug Design. Examples of their Applications in Medicinal Chemistry Current Medicinal Chemistry ·Frédéric Ooms	2000	105
3	Analysis of Conserved Active Site Residues in Monoamine Oxidase A and B and Their Three-dimensional Molecular Modeling Journal of Biological Chemistry ·Rani Maurice Geha, Kai Chen, Johan Wouters, Frédéric Ooms, Jean C. Shih	2002	86
4	A simple model to predict blood–brain barrier permeation from 3D molecular fields Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Frédéric Ooms, P. Weber, Pierre‐Alain Carrupt, Bernard Testa	2002	64
5	Exploration of the Pharmacophore of 3-Alkyl-5-Arylimidazolidinediones as New CB₁Cannabinoid Receptor Ligands and Potential Antagonists: Synthesis, Lipophilicity, Affinity, and Molecular Modeling Journal of Medicinal Chemistry ·Frédéric Ooms, Johan Wouters, Olivier Oscari, Thierry Happaerts, Géraldine Bouchard, Pierre‐Alain Carrupt, Bernard Testa, Didier M. Lambert	2002	37
6	Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5H-Indeno[1,2-c]pyridazin-5-one Core Journal of Medicinal Chemistry ·Raphaël Frédérick, Willy Dumont, Frédéric Ooms, Lindsey C. Aschenbach, Cornelis J. Van der Schyf, Neal Castagnoli, Johan Wouters, Alain Krief	2006	35
7	Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compound European Journal of Medicinal Chemistry ·Johan Wouters, Frédéric Ooms, Samir Jegham, J. J. Koenig, P. George, F. Durant	1997	25
8	Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication Journal of Pharmacology and Experimental Therapeutics ·Thierry Ferain, Hamid R. Hoveyda, Frédéric Ooms, Dominique Schols, Jérôme Bernard, Graeme L. Fraser	2011	17
9	Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative Bioorganic & Medicinal Chemistry Letters ·Frédéric Ooms, Raphaël Frédérick, F. Durant, Jacobus P. Petzer, Neal Castagnoli, Cornelis J. Van der Schyf, Johan Wouters	2003	13
10	Artificial Intelligence and Entrepreneurship: A Call for Research to Prospect and Establish the Scholarly AI Frontiers Entrepreneurship Theory and Practice ·Martin Obschonka, Denis A. Grégoire, Boris Nikolaev, Frédéric Ooms, Moren Lévesque, Jeffrey M. Pollack, Tara S. Behrend	2024	10
11	Molecular lipophilicity potential by clip, a reliable tool for the description of the 3D distribution of lipophilicity: Application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors Bioorganic & Medicinal Chemistry Letters ·Frédéric Ooms, Johan Wouters, Sonia Collin, F. Durant, Samir Jegham, Pascal George	1998	8
12	γ-Silyloxy-Benzyllithiums : Stereochemistry of the Retro-[1,4]-Brook Rearrangement Tetrahedron Letters ·J. Bousbaa, Frédéric Ooms, Alain Krief	1997	8
13	Small Molecule Crystallography in Drug Design Current Pharmaceutical Design ·Johan Wouters, Frédéric Ooms	2001	7
14	2-Oxazolidinone Acta Crystallographica Section C Crystal Structure Communications ·Johan Wouters, Frédéric Ooms, F. Durant	1997	6
15	Advancing (Neuro)Entrepreneurship Cognition Research Through Resting-State fMRI: A Methodological Brief Entrepreneurship Theory and Practice ·Frédéric Ooms, Jitka Annen, Rajanikant Panda, Paul Meunier, Luaba Tshibanda, Steven Laureys, Jeffrey M. Pollack, Bernard Surlemont	2023	6
16	(E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B Acta Crystallographica Section C Crystal Structure Communications ·Raphaël Frédérick, Frédéric Ooms, Neal Castagnoli, Jacobus P. Petzer, Jiang‐Fan Feng, Michael A. Schwarzschild, Cornelis J. Van der Schyf, Johan Wouters	2005	4
17	7-Nitroindazole Acta Crystallographica Section C Crystal Structure Communications ·Frédéric Ooms, Bernadette Norberg, Emre M. Isin, Neal Castagnoli, Cornelis J. Van der Schyf, Johan Wouters	2000	4
18	Verification of macro subsurface models using a shot record approach H. L. H. Cox, Frédéric Ooms, Kees Wapenaar, A. J. Berkhout	1988	4
19	Entrepreneurial neuroanatomy: Exploring gray matter volume in habitual entrepreneurs Journal of Business Venturing Insights ·Frédéric Ooms, Jitka Annen, Rajanikant Panda, Benedetta Cecconi, Bernard Surlemont, Steven Laureys	2024	3
20	Three 5H-indeno[1,2-c]pyridazin-5-one derivatives, potent type-B monoamine oxidase inhibitors Acta Crystallographica Section C Crystal Structure Communications ·Raphaël Frédérick, Bernadette Norberg, F. Durant, Frédéric Ooms, Johan Wouters	2004	2

About Frédéric Ooms

Frédéric Ooms is a scholar working on Organic Chemistry, Molecular Biology, Computational Theory and Mathematics, Spectroscopy and Pharmacology, having authored 25 papers that have together received 705 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), Analytical Chemistry and Chromatography (3 papers), Synthesis and biological activity (3 papers), Cyclopropane Reaction Mechanisms (3 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Synthesis and Biological Evaluation (2 papers), Creativity in Education and Neuroscience (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). The work is most often cited by research in Pharmacology (252 citations), Computational Theory and Mathematics (194 citations), Organic Chemistry (339 citations), Drug Discovery (1 citation) and Biological Psychiatry (12 citations). Frédéric Ooms has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Bernard Testa, Johan Wouters, Pierre‐Alain Carrupt, Cosimo Altomare, Marco Catto, Angelo Carotti, Francesco Leonetti, Kai Chen, Jean C. Shih and Pierre‐Alain Carrupt. Their work appears in journals such as Acta Crystallographica Section C Crystal Structure Communications, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Entrepreneurship Theory and Practice and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact